JP2011527340A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527340A5
JP2011527340A5 JP2011517314A JP2011517314A JP2011527340A5 JP 2011527340 A5 JP2011527340 A5 JP 2011527340A5 JP 2011517314 A JP2011517314 A JP 2011517314A JP 2011517314 A JP2011517314 A JP 2011517314A JP 2011527340 A5 JP2011527340 A5 JP 2011527340A5
Authority
JP
Japan
Prior art keywords
formula
alkenyl group
compound
composition according
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011517314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527340A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2009/000382 external-priority patent/WO2010004579A2/en
Publication of JP2011527340A publication Critical patent/JP2011527340A/ja
Publication of JP2011527340A5 publication Critical patent/JP2011527340A5/ja
Pending legal-status Critical Current

Links

JP2011517314A 2008-07-07 2009-07-06 経口活性クルクミノイド化合物 Pending JP2011527340A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1641CH2008 2008-07-07
IN1641/CHE/2008 2008-07-07
PCT/IN2009/000382 WO2010004579A2 (en) 2008-07-07 2009-07-06 Orally active curcuminoid compounds

Publications (2)

Publication Number Publication Date
JP2011527340A JP2011527340A (ja) 2011-10-27
JP2011527340A5 true JP2011527340A5 (enExample) 2012-08-23

Family

ID=41507515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011517314A Pending JP2011527340A (ja) 2008-07-07 2009-07-06 経口活性クルクミノイド化合物

Country Status (6)

Country Link
US (1) US8680143B2 (enExample)
EP (1) EP2294049A4 (enExample)
JP (1) JP2011527340A (enExample)
CN (1) CN102131765A (enExample)
AU (1) AU2009269530A1 (enExample)
WO (1) WO2010004579A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015186144A2 (en) * 2014-06-07 2015-12-10 Laila Pharmaceuticals Pvt. Ltd. Method of inhibition of beta-secretase by using bis-o-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases
US10085951B2 (en) 2014-12-11 2018-10-02 Designs For Health, Inc. Curcuminoid formulations and related methods of treatment
JP6814240B2 (ja) 2018-03-23 2021-01-13 メリー ライフ ビオメディカル カンパニー,リミテッドMerry Life Biomedical Company,Ltd. クルクミン誘導体の使用
CN112315953B (zh) * 2020-11-06 2023-03-07 中国海洋大学 一种姜黄素酯在改善急性肾损伤制品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031122A1 (de) * 2002-10-01 2004-04-15 Dr. André Rieks - Labor Für Enzymtechnologie Gmbh Neue curcumin/tetrahydrocurcumin-derivate für den einsatz in kosmetika, pharmazeutika und bei der ernährung
EP1876908A1 (en) 2005-05-03 2008-01-16 DSMIP Assets B.V. Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives
WO2007103435A2 (en) * 2006-03-06 2007-09-13 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
CN101454267B (zh) * 2006-03-29 2012-09-26 帝斯曼知识产权资产管理有限公司 姜黄素的合成
EP2813145A1 (en) * 2006-10-12 2014-12-17 Research Foundation Of The City University Of New York Novel curcumin and tetrahydrocurcumin derivatives

Similar Documents

Publication Publication Date Title
JP2009507909A5 (enExample)
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
JP2013510120A5 (enExample)
JP2019529490A5 (enExample)
JP2014521688A5 (enExample)
JP2014511892A5 (enExample)
JP2010540509A5 (enExample)
JP2011509309A5 (enExample)
CA2637765A1 (en) Benzamide and heteroarene derivatives
JP2013519645A5 (enExample)
JP2017533968A5 (enExample)
JP2013518107A5 (enExample)
JP2013542261A5 (enExample)
JP2015505296A5 (enExample)
JP2012513416A5 (enExample)
JP2016074736A5 (enExample)
JP2009143956A5 (enExample)
JP2016505586A5 (enExample)
JP2014515406A5 (enExample)
JP2009502743A5 (enExample)
JP2013508279A5 (enExample)
JP2014511891A5 (enExample)
JP2012506872A5 (enExample)
JP2014501766A5 (enExample)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она